CLINICAL_TRIALS
trial_result
· 2018-11-29
Clinical Trial Update: Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis [NA]
Summary
Completed clinical trial evaluating ambrisentan in combination with an antifibrotic agent for diffuse systemic sclerosis; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Systemic Sclerosis, Scleroderma | NA | Status: COMPLETED | Results posted: 2018-11-29